We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Arecor Therapeutics Plc | LSE:AREC | London | Ordinary Share | GB00BMWLM973 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 128.50 | 127.00 | 130.00 | 128.50 | 128.50 | 128.50 | 3,300 | 08:00:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 3.54M | -9.26M | -0.3024 | -4.25 | 39.35M |
TIDMAREC
RNS Number : 1449V
Arecor Therapeutics PLC
05 August 2022
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BMWLM973
Issuer Name
Arecor Therapeutics plc
UK or Non-UK Issuer
UK
2. Reason for Notification
An event changing the breakdown of voting
3. Details of person subject to the notification obligation
Name
Oxford technology 2 VCT Plc
City of registered office (if applicable)
Oxford
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Name City of registered office Country of registered office Oxford Technology 2 VCT plc Oxford UK =========================== ==============================
5. Date on which the threshold was crossed or reached
04-Aug-2022
6. Date on which Issuer notified
05-Aug-2022
7. Total positions of person(s) subject to the notification obligation
% of voting rights % of voting rights Total of both in % Total number of attached to shares through financial (8.A + 8.B) voting rights held (total of 8.A) instruments (total in issuer of 8.B 1 + 8.B 2) Resulting situation on the date on which threshold was crossed or reached 5.208085 0.000000 5.208085 1587776 ====================== ====================== ====================== ====================== Position of previous notification (if applicable) 0.000000 ====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type Number of direct voting Number of indirect % of direct voting % of indirect voting of shares ISIN rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1) code(if possible) (DTR5.2.1) GB00BMWLM973 1587776 5.208085 % ======================= ====================== ======================= ======================= Sub Total 8.A 1587776 5.208085 % =============================================== ================================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights that may % of voting rights instrument be acquired if the instrument is exercised/converted Sub Total 8.B1 =========================================== ================================== ==================
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights financial period settlement rights instrument Sub Total 8.B2 =========================================================== ===================== ==================
9. Information in relation to the person subject to the notification obligation
1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
Ultimate Name of controlled % of voting rights if it % of voting rights Total of both if it controlling undertaking equals or is higher than through financial equals or is higher than person the notifiable threshold instruments if it equals the notifiable threshold or is higher than the notifiable threshold
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
05-Aug-2022
13. Place Of Completion
Oxford, UK
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLUVUSRUBUWRAR
(END) Dow Jones Newswires
August 05, 2022 10:33 ET (14:33 GMT)
1 Year Arecor Therapeutics Chart |
1 Month Arecor Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions